Abstract
Sleep is crucial for overall physical and mental health, concerning organs such as the brain, heart, eye, liver, kidney, and lung. Nonetheless, a thorough understanding of how sleep relates to these organs, as well as their genetic bases, remains elusive. Here we conducted a systematic mapping of sleep-organ connections, focusing on 623 multi-organ imaging biomarkers and 10 sleep traits. Both phenotypic and genetic analyses uncovered robust associations between sleep and the structure and function of multiple organs, such as brain functions measured by functional magnetic resonance imaging (fMRI) and body composition traits in abdominal MRI. Sleep and imaging traits had shared genetic influences in 51 genomic loci, 23 of which had colocalized causal genetic effects. Considering the extensive genetic overlaps between sleep and multi-organ imaging biomarkers, we further described the patterns of genetic similarities between sleep and 50 diseases relevant to these organs. Notably, among all diseases examined, psychiatric disorders consistently exhibited the strongest genetic correlations and causal links with sleep. Mediation analysis further revealed that many of the identified sleep-imaging connections were mediated by intra or inter-organ diseases. Overall, our study demonstrates the broad implications of sleep on brain and body health, influenced in part by shared genetic factors.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research reported in this publication was supported by the National Institute On Aging of the National Institutes of Health under Award Number RF1AG082938. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The study has also been partially supported by funding from the Purdue University Statistics Department and the Department of Statistics and Data Science at the University of Pennsylvania. Assistance for this project was also provided by the UNC Intellectual and Developmental Disabilities Research Center (NICHD; P50 HD103573).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We use the data from the UK Biobank (UKB). The data can be obtained from https://www.ukbiobank.ac.uk/. The ethics approval of the UKB study was from the North West Multicentre Research Ethics Committee (approval number: 11/NW/0382).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.